Life Link Research vs Core Peptides — Comparison for 2026

Life Link Research and Core Peptides are both US-based research peptide suppliers. The defining difference between them: Core Peptides relies on internal COA testing; Life Link Research uses six-panel third-party independent verification. Given what happened to vendors using internal-only verification (Amino Asylum, Paradigm Peptides), this difference is the central factor in 2026 sourcing decisions.

Quick Comparison

Factor	Life Link Research	Core Peptides
COA standard	Six-panel third-party independent	Internal testing referenced on most COAs
COA available before purchase	Yes	Varies
GLP-1 range	Full	Partial
SARMs in catalog	No	No
Years in market	Newer	Long-running

The verification gap is specific: independent mass spectrometry on every batch is the testing standard that would have detected the testosterone-adulterated SARMs at Amino Asylum and Paradigm. Vendors that rely on internal verification carry that same systemic risk.

Core Peptides has a longer market track record, which is a real advantage for researchers prioritizing supplier stability. But the documentation standard is the more important factor for research validity in the post-2025 environment.

When to Choose Each

Choose Life Link Research if independent documentation matters for your research workflow, or if you need the newest GLP-1 compounds.

Choose Core Peptides if you prefer an established vendor with classic peptides and your research isn’t dependent on independently verified COAs.

FAQs

What’s the difference between internal and third-party COAs?

Internal: the vendor tests in their own lab. Third-party: an independent laboratory tests, with no commercial stake in the result.

Why does this matter?

Independent verification is the control that prevents adulteration. The FDA prosecutions of 2025 all hinged on adulteration that internal testing didn’t catch.

View Life Link Research products →

For research purposes only. Not for human use.